Exon Array Analyses across the NCI-60 Reveal Potential Regulation of TOP1 by Transcription Pausing at Guanosine Quartets in the First Intron

被引:57
作者
Reinhold, William C. [1 ]
Mergny, Jean-Louis [3 ]
Liu, Hongfang [1 ,4 ]
Ryan, Michael [5 ]
Pfister, Thomas D. [6 ]
Kinders, Robert [6 ]
Parchment, Ralph [6 ]
Doroshow, James [1 ,2 ]
Weinstein, John N. [7 ,8 ]
Pommier, Yves [1 ]
机构
[1] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20894 USA
[2] NCI, Dev Therapeut Program, Ctr Canc Res, NIH, Bethesda, MD 20894 USA
[3] Museum Natl Hist Nat USM 503, Inst Natl Sante & Rech Med U565, Regulat & Dynam Genomes Lab Biophys, Paris, France
[4] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
[5] Tiger Team Consulting, Fairfax, VA USA
[6] NCI, Lab Human Toxicol & Pharmacol, Appl Dev Res Support Directorate, Sci Applicat Int Corp Frederick, Frederick, MD 21701 USA
[7] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
[8] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA
关键词
CANCER-CELL LINES; TOPOISOMERASE-I INHIBITORS; RNA-POLYMERASE-II; DNA TOPOISOMERASES; PROMOTER; EXPRESSION; GENE; MICROARRAY; PANEL; CAMPTOTHECIN;
D O I
10.1158/0008-5472.CAN-09-3528
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Because topoisomerase 1 (TOP1) is critical for the relaxation of DNA supercoils and because it is the target for the anticancer activity of camptothecins, we assessed TOP1 transcript levels in the 60 cell line panel (the NCI-60) of the National Cancer Institute's anticancer drug screen. TOP1 expression levels varied over a 5.7-fold range across the NCI-60. HCT116 colon and MCF-7 breast cancer cells were the highest expressers; SK-MEL-28 melanoma and HS578T breast carcinoma cells were the lowest. TOP1 mRNA expression was highly correlated with Top1 protein levels, indicating that TOP1 transcripts could be conveniently used to monitor Top1 protein levels and activity in tissues. Assessment of the TOP1 locus by array comparative genomic hybridization across the NCI-60 showed copy numbers ranging from 1.71 to 4.13 and a statistically significant correlation with TOP1 transcript levels (P < 0.01). Further analyses of TOP1 expression on an exon-specific basis revealed that exon 1 expression was generally higher and less variable than expression of the other exons, suggesting some form of transcriptional pausing regulation between exons 1 and 2. Accordingly, we found the presence of multiple evolutionarily conserved potential G-quadruplex-forming sequences in the first TOP1 intron. Physicochemical tests for actual quadruplex formation by several of those sequences yielded quadruplex formation for two of them and duplex formation for one. The observations reported here suggest the hypothesis that there is a conserved negative transcription regulator within intron 1 of the TOP1 gene associated with a quadruplex-prone region. Cancer Res; 70(6); 2191-203. (C) 2010 AACR.
引用
收藏
页码:2191 / 2203
页数:13
相关论文
共 42 条
[1]   Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topolsomerase I cleavage complexes and overcome multidrug resistance [J].
Antony, Smitha ;
Agama, Keli K. ;
Miao, Ze-Hong ;
Takagi, Kazutaka ;
Wright, Mollie H. ;
Robles, Ana I. ;
Varticovski, Lyuba ;
Nagarajan, Muthukaman ;
Morrell, Andrew ;
Cushman, Mark ;
Pommier, Yves .
CANCER RESEARCH, 2007, 67 (21) :10397-10405
[2]   A triplex-forming sequence from the human c-MYC promoter interferes with DNA transcription [J].
Belotserkovskii, Boris P. ;
De Silva, Erandi ;
Tornaletti, Silvia ;
Wang, Guliang ;
Vasquez, Karen M. ;
Hanawalt, Philip C. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (44) :32433-32441
[3]   SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN [J].
BOYD, MR ;
PAULI, KD .
DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) :91-109
[4]   Predictive biomarkers of chemotherapy efficacy in colorectal cancer: Results from the UK MRC FOCUS trial [J].
Braun, Michael S. ;
Richman, Susan D. ;
Quirke, Philip ;
Daly, Catherine ;
Adlard, Julian W. ;
Elliott, Faye ;
Barrett, Jennifer H. ;
Selby, Peter ;
Meade, Angela M. ;
Stephens, Richard J. ;
Parmar, Mahesh K. B. ;
Seymour, Matthew T. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) :2690-2698
[5]   Topoisomerase levels determine chemotherapy response in vitro and in vivo [J].
Burgess, Darren J. ;
Doles, Jason ;
Zender, Lars ;
Xue, Wen ;
Ma, Beicong ;
McCombie, W. Richard ;
Hannon, Gregory J. ;
Lowe, Scott W. ;
Hemann, Michael T. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (26) :9053-9058
[6]   Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel [J].
Bussey, KJ ;
Chin, K ;
Lababidi, S ;
Reimers, M ;
Reinhold, WC ;
Kuo, WL ;
Gwadry, F ;
Jain, A ;
Kouros-Mehr, H ;
Fridlyand, J ;
Jain, A ;
Collins, C ;
Nishizuka, S ;
Tonon, G ;
Roschke, A ;
Gehlhaus, K ;
Kirsch, I ;
Scudiero, DA ;
Gray, JW ;
Weinstein, JN .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (04) :853-867
[7]   OLIGONUCLEOTIDE INTERACTIONS .3. CIRCULAR DICHROISM STUDIES OF CONFORMATION OF DEOXYOLIGONUCLEOTIDES [J].
CANTOR, CR ;
WARSHAW, MM ;
SHAPIRO, H .
BIOPOLYMERS, 1970, 9 (09) :1059-&
[8]   DNA topoisomerases: Structure, function, and mechanism [J].
Champoux, JJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 :369-413
[9]   G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription [J].
Cogoi, Susanna ;
Xodo, Luigi E. .
NUCLEIC ACIDS RESEARCH, 2006, 34 (09) :2536-2549
[10]   Transcription regulation through promoter-proximal pausing of RNA polymerase II [J].
Core, Leighton J. ;
Lis, John T. .
SCIENCE, 2008, 319 (5871) :1791-1792